They can help you balance the risks and the benefits of this medicine during pregnancy. You should seek advice from your doctor or pharmacist about taking this medicine. Pregnant or planning a pregnancy?įor the active ingredient medroxyprogesterone To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website. This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2021. open tool tip to find out more Is this medicine subsidised? This medicine is available from a pharmacist and requires a prescription. You can read more about the scheduling of medicines as well as the different scheduling categories on our Scheduling of medicines and poisons information page. Medicines with a low safety risk are usually less tightly controlled than medicines with a higher safety risk. What is the medicines and poisons schedule?Īll medicines and poisons in Australia are categorised by how they are made available to the public. White suspension Do I need a prescription? If symptoms persist see your healthcare professional. You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.Īlways read the label. This medicine is given through a needle inserted into the muscle beneath the skin. The way to take this medicine is: Intramuscular. The injection, DEPO-PROVERA 150 mg/1mL, should be used for contraception. The 50 mg/1mL vial is not approved for the indication of contraception (ovulation suppression). Women under the age of 18 years may be at risk of failing to achieve their predicted peak bone mineral density (See WARNINGS). Since loss of bone mineral density (BMD) may occur in pre-menopausal women who use DEPO-PROVERA long-term (greater than 2 years), women should be assessed, before starting treatment for contraception or endometriosis, regarding the risk of osteoporosis. Contraception (ovulation suppression): For long-term prevention of pregnancy in women when administered at 3-month intervals. Endometriosis: For use in the treatment of visually proven (laparoscopy) endometriosis where the required end-point of treatment is pregnancy, or for the control of symptoms when surgery is contra- indicated or has been unsuccessful. Carcinoma: Palliative treatment of recurrent and/or metastatic breast or renal cell cancer and of inoperable recurrent or metastatic endometrial carcinoma.
0 kommentar(er)
